Inflammatory talk: Linking Obesity, NF-κB, and aromatase

Cancer Prevention Research

Volumn 4, Issue 3, 2011, Pages 285-287

  Hursting, Stephen D ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; AROMATASE; CYCLOOXYGENASE 2; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL MODEL; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PREVENTION; CONCEPTUAL FRAMEWORK; DRUG TARGETING; HUMAN; MENOPAUSE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOLECULAR MODEL; NONHUMAN; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANIMALS; AROMATASE; BREAST NEOPLASMS; EPITHELIAL CELLS; FATTY ACIDS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; MACROPHAGES; MICE; NF-KAPPA B; OBESITY; SIGNAL TRANSDUCTION;

EID: 79955835672     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0056     Document Type: Short Survey

References (14)

1. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Rel Cancer 2006;13:279-92. (Pubitemid 43886659)
2. Hursting SD, Berger N. Energy balance, host-related factors and cancer progression. J Clin Oncol 2010;28:4058-65.
3. Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res 2011;4:329-346.
4. Nunez NP, Perkins SN, Smith NCP, Berrigan D, Berendes DM, Varticovski L, et al. Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutr Cancer 2008;60:534-41. (Pubitemid 351918549)
5. Murano I, Barbatelli G, Parisani V, Latini C, Muzzonigro G, Castellucci M, et al. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically-obese mice. J Lipid Res 2008;49:1562-68.
6. Altintas MM, Azad A, Nayer B, Contreras G, Zalas J, Faul C, et al. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res 2010; epub ahead of print.
7. Hursting SD, Nunez NP, Varticovski L, Vinson C. The obesity-cancer link: lessons learned from a fatless mouse. Cancer Res 2007;67:2391-93. (Pubitemid 46548919)
8. Lin CS, Xin ZC, Deng CH, Ning H, Lin G, Lue TF. Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol 2010;25:807-15.
9. Fagan DH, Yee D. Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 2008;13:423-9.
10. Mawson A, Lai A, Carroll JS, Sergio CM, Mitchell CJ, Sarcevic B. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1. Mol Cell Endocrinol 2005;229:161-73. (Pubitemid 40018094)
11. Sachdev D, Yee D. The IGF system and breast cancer. Endocr Relat Cancer 2001;8:197-209. (Pubitemid 32947642)
12. Olivo-Marston SE, Hursting SD, Lavigne J, Perkins SN, Maarouf RS, Yakar S, et al. Genetic reduction of circulating insulin-like growth factor-1 inhibits azoxymethane-induced colon tumorigenesis in mice. Mol Carcinog 2009;48:1071-6.
13. Lashinger LM, Malone LM, MacArthur MJ, Daniels EA, Pavone A, Colby JK, et al. Genetic reduction of insulin-like growth factor-1 mimics the anticancer effects of calorie restriction on cyclooxygenase-2 driven pancreatic cancer. Cancer Prev Res 2011;in press.
14. Mitsiades CS, Mitsiades N, Poulaki V, Schlossman R, Akiyama M, Chauhan D, et al. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene 2002;21:5673-83. (Pubitemid 35333000)